A Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Patients With IBS-D

PHASE3RecruitingINTERVENTIONAL

Enrollment

1,298

Participants

Timeline

Start Date

March 16, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

January 31, 2027

Conditions

Irritable Bowel Syndrome With Diarrhea

Interventions

DRUG

Live SK08 powder

Oral Powder

DRUG

Placebo

Oral Powder

Trial Locations (2)

RECRUITING

Wuxi People's Hospital, Wuxi

RECRUITING

Binzhou Medical University Hospital, Binzhou

All Listed Sponsors

lead

Guangzhou Zhiyi Biotechnology Co., Ltd.

OTHER